Days Sales in Receivables: The average number of days it takes to collect outstanding receivable amounts from customers. Calculated as: Number of Days in Period / Receivable Turnover
Cytek Biosciences, Inc. (CTKB) had Days Sales in Receivables of 90.53 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$62.14M |
|
$-44.08M |
|
$29.26M |
|
$32.88M |
|
$67.73M |
|
$-5.59M |
|
$1.56M |
|
$-4.03M |
|
$-4.03M |
|
$-44.08M |
|
$-44.08M |
|
$-44.08M |
|
$-44.08M |
|
$-5.59M |
|
$-2.55M |
|
127.75M |
|
127.75M |
|
$-0.35 |
|
$-0.35 |
|
| Balance Sheet Financials | |
$392.00M |
|
$18.01M |
|
$69.55M |
|
$461.54M |
|
$77.80M |
|
$0.53M |
|
$42.00M |
|
$119.80M |
|
$341.74M |
|
$308.22M |
|
$341.74M |
|
128.55M |
|
| Cash Flow Statement Financials | |
$-4.69M |
|
$10.12M |
|
$-13.43M |
|
$98.75M |
|
$90.85M |
|
$-7.89M |
|
$24.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.04 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
52.92% |
|
-9.00% |
|
-9.00% |
|
-- |
|
-6.49% |
|
-70.93% |
|
$-8.52M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
0.60 |
|
0.99 |
|
|
Days Sales in Receivables |
90.53 |
-12.90% |
|
-14.30% |
|
-9.55% |
|
-12.88% |
|
$2.66 |
|
$-0.07 |
|
$-0.04 |
|